Sr. Manager/Associate Director, R&D Program Manager

About Voyager

We are Voyager Therapeutics, a pre-clinical stage biotech compelled by curiosity and powered by persistence. Voyagers are bold innovators who are energized in unlocking the full potential of AAV gene therapy employing our TRACERTM capsid discovery platform. Our resolve is to advance the field of AAV gene therapy, and through our innovative capsids, we are extending the reach and impact of our technology to help more patients in need.

Recognizing that we can expand on the experience, innovation, and outcomes that propel our efforts by working together, we actively seek diverse views. If you’re someone who wants to make discoveries that change the landscape of medicine for patients, we want you on our team!

Job Summary

Voyager is seeking a motivated and energetic Program Manager to drive execution of assigned R&D programs from pre-IND through clinical development to regulatory approval. You will ensure alignment with the overall Voyager strategy and drive achievement of the company goals through excellence in project management of cross-functional teams. The Program Manager will also work closely with the functional leaders to ensure integration and agreement on the overall program goals and resourcing. You are a team-player who is self-motivated, detail-oriented, can multi-task, understands the broader context and impact you will provide and know how to identify issues and proactively propose solutions. Strong experience working as a PM in research and development is a must.

Key Responsibilities

• Deliver consistent and high-quality project management services to enable team and project success by being strategic in project planning, team management and process management


• Partner with Program team leader to set, monitor strategy and team goals


• Responsible for team activity timelines/dashboards (creation and maintenance of the integrated program plan), strong team management, collaboration and continuous improvement


• Play an important role in communication by leading project management efforts including leading face-to-face meetings, development of agendas, creation of meeting minutes, tracking of action items, and scheduling of follow-up meetings


• Facilitate cross-functional planning of activities across departments and program teams to align dependencies, schedules, budgets and delivery commitments


• Help manage team interactions and ensure that input from appropriate team members is obtained to promote informed decision making


• Proactively identify potential risks, resource constraints, and conflicts that could impact project timelines; collaborate with the development team to develop appropriate solutions


• Help prepare presentations for executive, board and functional leaders and teams


• Work as part of a centralized Project Management function, contributing to cross departmental collaboration and continuous process improvement


• Demonstrate ability to engage and effectively influence team members

Qualifications

• BS degree in relevant life science discipline with at least 5 years relevant industry experience, and 3 years' experience in a project management and/or leadership experience supporting/leading cross-functional teams in a scientific environment


• Thorough understanding of drug development at all stages across research and development


• Early-stage CMC experience


• Gene therapy experience strongly preferred


• Leadership skills to be effective in a matrixed organization with geographically dispersed teams

Differentiators from other applicants

• IND filing and Phase I experience


• Experience in multiple neuroscience therapeutic areas


• PMP certification or MBA is a plus


• Change Management certification

Voyager Therapeutics requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment.  Voyager Therapeutics will consider reasonable accommodations as required by federal, state, and local laws.

About Voyager Therapeutics
Voyager Therapeutics (Nasdaq: VYGR) is a biotechnology company dedicated to breaking through barriers in gene therapy and neurology. The potential of both disciplines has been constrained by delivery challenges; Voyager is leveraging cutting-edge expertise in capsid discovery and deep neuropharmacology capabilities to address these constraints. Voyager’s TRACER AAV capsid discovery platform has generated novel capsids with high target delivery and blood-brain barrier penetration at low doses, potentially addressing the narrow therapeutic window associated with conventional gene therapy delivery vectors. This platform is fueling alliances with Pfizer Inc., Novartis and Neurocrine Biosciences as well as multiple programs in Voyager’s own pipeline. Voyager’s pipeline includes preclinical programs in Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis (ALS), each with validated targets and biomarkers to enable a path to rapid potential proof-of-biology. For more information, visit www.voyagertherapeutics.com.

Voyager Therapeutics® is a registered trademark, and TRACER™ is a trademark, of Voyager Therapeutics, Inc.